Bridgewater Associates - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$812,372
-16.5%
42,267
+10.4%
0.01%
-16.7%
Q2 2023$972,849
-36.7%
38,271
-10.0%
0.01%
-33.3%
Q1 2023$1,536,411
-5.2%
42,501
+3.8%
0.01%0.0%
Q4 2022$1,621,026
-36.7%
40,935
-25.5%
0.01%
-30.8%
Q3 2022$2,559,000
+6.5%
54,915
+0.2%
0.01%
+30.0%
Q2 2022$2,402,000
-31.9%
54,810
+12.5%
0.01%
-28.6%
Q1 2022$3,525,000
+17.2%
48,735
+31.4%
0.01%
-17.6%
Q4 2021$3,007,000
-20.1%
37,092
+14.7%
0.02%
-19.0%
Q3 2021$3,763,000
-34.7%
32,334
-7.0%
0.02%
-43.2%
Q2 2021$5,765,00034,7730.04%
Other shareholders
NEVRO CORP shareholders Q1 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders